Loading...
NPI 1083656805 · Honolulu, HI · Pharmacy
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Longs Drug Stores California LLC is a pharmacy provider located in Honolulu, Hawaii. This profile covers 10 Medicare and 13 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Longs Drug Stores California LLC |
| Address | 4211 Waialae Ave |
| City | Honolulu |
| State | HI |
| ZIP | 96816 |
| Taxonomy | Pharmacy |
| NPI Enumerated | June 13, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $380K |
| Medicaid | $56.9K |
LONGS DRUG STORES CALIFORNIA LLC is registered as a pharmacy in HONOLULU and was enumerated on 2006-06-13 (~20 years ago), indicating long tenure in Medicare/Medicaid billing. Its lifetime Medicare revenue ($380K) is an order of magnitude larger than its lifetime Medicaid revenue ($56.9K), so the provider’s Medicare business dominates its public-payer footprint.
The provider’s Medicare billing mix is concentrated in immunizations and COVID-related services: 91320 (COVID-19 vaccine) generated $115.1K, K1034 (nonprescription self-administered COVID test) accounted for $110.3K, and 90480 (COVID-19 vaccine administration) contributed $38.7K. Those three Medicare codes together drive 68.9% of the provider’s Medicare revenue, which points to a pharmacy operating with a heavy focus on vaccination and mass distribution of COVID testing.
Medicaid billing shows a different composition and lower scale: the top three Medicaid codes 0002A, 91320, and 0001A produce 45.6% of Medicaid revenue, with individual Medicaid top-line contributions of $9.6K (0002A) and $9.4K (91320). The Medicaid mix is more distributed across multiple CPT/HCPCS values compared with Medicare, indicating less dependence on a single service line in the state program.
Competitive standing on Medicare for COVID-related services is high by rank but characterized as routine by code-level descriptors: 91320 ranks #88 of 27083 (100th percentile; typical, unremarkable volume), K1034 ranks #333 of 30143 (99th percentile; typical, unremarkable volume), and 90480 ranks #180 of 46950 (100th percentile; typical, unremarkable volume). In plain terms, the pharmacy appears among the top-ranked national billers for these codes by volume, but the vendor-supplied labels classify the activity as within expected ranges for providers who offer these services.
Within Medicaid (in-state) the provider is a modest regional participant: 91320 ranks #5 of 19 providers in-state (78th percentile) while 0002A and 0001A rank in the 61st–63rd percentiles for Hawaii. These ranks suggest the pharmacy is competitive on select Medicaid vaccine/test services but is not a dominant statewide leader across the full set of Medicaid codes.
There is a clear operational split between high-volume, low-paid testing and lower-volume, higher-paid vaccine services: Medicare shows K1034 with 9.2K claims at $12 avg paid/claim versus vaccine code 91320 with 899 claims at $128 avg paid/claim and 90480 with 900 claims at $43 avg paid/claim. This pattern is consistent with a retail pharmacy model that handles large-scale distribution of self-test kits while also delivering fee-for-service immunizations.
A few codes stand out relative to peers: Medicare code 0121A (62 claims, $2.7K revenue) ranks #12 of 713 providers nationally (98th percentile; notably above typical national volume), indicating unusually strong activity on that specific code compared with peers. On the Medicaid side, 0124A ranks #6 of 39 in-state (87th percentile), which similarly points to above-typical in-state utilization for that code and may merit focused review if code-level operational or contract details are relevant.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
10 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 900 | $130 | $115.1K |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 9,190 | $10 | $110.3K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 900 | $40 | $38.7K |
| 90694 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL… | 440 | $80 | $33K |
| G0008 | Administration of influenza virus vaccine | 740 | $30 | $22.9K |
| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 80 | $280 | $21.5K |
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 290 | $70 | $21K |
| 0124A | N/A | 400 | $40 | $17.2K |
| 0121A | N/A | 60 | $40 | $2.7K |
| G0009 | Administration of pneumococcal vaccine | 80 | $10 | $840 |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 10 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
13 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 0002A | N/A | 250 | $40 | $9.6K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 90 | $100 | $9.4K |
| 0001A | N/A | 240 | $30 | $7K |
| 0004A | N/A | 160 | $40 | $6.1K |
| 0054A | N/A | 110 | $40 | $4.4K |
| 0124A | N/A | 90 | $40 | $3.8K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 90 | $40 | $3.8K |
| 90471 | In this procedure, the provider administers a live attenuated vaccine using a percutaneous, intradermal, subcutaneous, or intramuscular route. | 340 | $10 | $3.7K |
| 0071A | N/A | 70 | $40 | $2.9K |
| 0072A | N/A | 70 | $40 | $2.9K |
Showing 1–10 of 13
How this provider's Medicaid billing volume and revenue compare to other Hawaii providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Hawaii median
13 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 0002A | N/A | 29 | 70 | 160 | $40 | $20.8K |
| 0001A | N/A | 30 | 80 | 140 | $30 | $18.4K |
| 90471 | In this procedure, the provider administers a live attenuated vaccine using a percutaneous, intradermal, subcutaneous, or intramuscular route. | 75 | 230 | 140 | $20 | $16.1K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 5 | 20 | 30 | $120 | $12.1K |
| 0004A | N/A | 11 | 50 | 50 | $30 | $5.6K |
| 0072A | N/A | 19 | 50 | 50 | $30 | $5.1K |
| 0071A | N/A | 20 | 50 | 50 | $30 | $4.9K |
| 90686 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is preservative free, uses split virus technology, and is given as a 0.5 mL… | 81 | 180 | 120 | $10 | $4.7K |
| 0054A | N/A | 9 | 40 | 80 | $30 | $4.5K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 13 | 60 | 50 | $30 | $2.8K |
Showing 1–10 of 13
Other providers in the same ZIP code as Longs Drug Stores California LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.